Since a couple of decades, metal-containing drugs have been successfully used to fight against certain types of cancer. The lack of knowledge about the underlying molecular mechanisms slows down the search for new and more efficient chemotherapeutic agents. Scientists have now developed a protocol that is able to detect how metal-based drugs interact with DNA.